Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.)
The " Safety assessment outside of Drug development (e.g.
Category
Format
Credits
CAR Therapy
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics
Category
  • Immunosafety
Format
  • Video
Credits
  • 0.50 Participation
CD3-binding (T cell engaging) immune stimulating antibody-based therapies
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics
Category
  • Immunosafety
Format
  • Video
Credits
  • 0.50 Participation
Gene Therapy
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therape
Category
  • Immunosafety
Format
  • Video
Credits
  • 0.50 Participation
Immunomodulating therapies (overview)
The "Immunomodulating therapies (overview) course is 1 of 18 courses included in the Introduction to Immuno-Safety Science module. This cour
Category
Format
Credits
Safety Considerations for Oligonucleotides
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics
Category
  • Immunosafety
Format
  • Video
Credits
  • 0.50 Participation
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities)
The "T cell targeting therapies (e.g.
Category
Format
Credits
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities)
The "B cell targeting therapies (e.g.
Category
Format
Credits
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities)
The "Innate immune cell therapies (e.g.
Category
Format
Credits
Immunopathology: evaluation, assessment, and considerations
The "Immunopathology: evaluation, assessment, and considerations" is 1 of 18 courses in the Introduction to Immuno-Safety Science module. This course is led by Dr.
Category
Format
Credits

Pages